Catalyst Wire Dossier Catalyst Wire Dossier

Denosumab (Prolia/Xgeva)

denosumab · Amgen
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Denosumab (Prolia/Xgeva), covering 2017-08-11 to 2025-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients [Phase 4]

See pricing